Definition :
Ascites refers to the accumulation of free
fluid in the peritoneal cavity .
•
CAUSES OF ASCITES
Common causes
Common causes
•
Malignant disease
–
Hepatic
–
Peritoneal
•
Cardiac failure
•
Hepatic cirrhosis
•
Hypoproteinaemia
–
Nephrotic syndrome
–
Protein-losing enteropathy
–
Malnutrition
•
Hepatic venous occlusion
–
Budd-Chiari syndrome
–
Veno-occlusive disease
•
Pancreatitis
•
Lymphatic obstruction
•
Infection
–
Tuberculosis
–
Spontaneous bacterial peritonitis
•
Rare
–
Meigs' syndrome
–
Vasculitis
–
Hypothyroidism
_ Renal dialysis
- According to the appearance of
ascitic fluid
Straw – coloured
Malignancy
Exudate
T . B
S B P
Transudate L ¢
CHF
Const pericandites
Megic synrome
Nephrotic
syndrome
ii
Chylous
Iii Haemorrhagic
–
Malignancy
–
Rupture ectopic pregnancy
–
Acute Pancreatitis
–
Clinical features
–
Ascites causes abdominal distension with fullness in
the flanks, shifting dullness on percussion and when the ascites is marked, a
fluid thrill .
–
These signs do not appear until the ascites volume exceeds
1 litre, even in thin patients, and much larger volumes can be hard to detect
in the obese.
- Associated
features of ascites include
distortion or eversion of the umbilicus, - herniae,
- abdominal
striae,
- divercation
of the recti
- scrotal
oedema.
- Pleural
effusions are found in about 10% of patients, usually on the right side
(hepatic hydrothorax); most are small and only identified on chest X-ray .-
- Pathogenesis
of ascites in cirrhosis
- Sodium
and water retention.
Peripheral arterial vasodilatation (by NO and prostaglandin) with
reduction in the effective blood volume,activate rennin-angiotensin system→
salt and water retention.
2. Portal hypertension :
P H leads to↑ hydrostatic pressure,
increased hepatic and splanchnic production of lymph and transudation of fluid
into the peritoneal cavity
3. Low serum albumin
Leading to decreased albumin plasma
oncotic pressure.
Theories of Ascites secondary to L ¢
Under filling theory :
Ascites lead to decrease intravascular volume,
Release of renin , aldosterone and ADH,
Na and water retention → increase ascites formation.
Over filling theory:
Systemic VD excessive renal reabsorption of Na
and water hypervolemia → overflow of fluid into peritoneum .
Investigations
1- Cause :
Liver function tests
Kidney function tests
Abdominal ultrasonographly
Echo cardiography
2- Laparoscopy :
Peritoneal tumours
T . B
3- Tapping and
ascitic fluid examination :
Bacteriology , culture and
sensitivity
Protein content
•
Cirrhotic patients typically develop a
transudate with a total protein concentration below 2,5 g/l and relatively few
cells.
•
However, in up to 30% of patients, the total
protein concentration is more than 30 g/l. In these cases it is useful to
calculate the serum-ascites albumin gradient by subtracting the concentration
of the ascites fluid albumin from the serum albumin.( SAAG )
•
SAAG = serum albumin – Ascitic fluid albumin
•
≥ 1.1 gm / dl = portal hypertensive
•
ascites
•
≤ 1.1 gm / dl = non portal
•
hypertensive ascites
•
A gradient of more than 1,1 g/l is strongly
suggestive of portal hypertension and cirrhosis.
•
Exudative ascites
•
(ascites protein concentration above 25
g/l or a serum-ascites albumin gradient of less than
11 g/l) raises the possibility of infection (especially tuberculosis),
malignancy, hepatic venous obstruction, pancreatic ascites
or, rarely, hypothyroidism Ascites
amylase activity above 1000 U/l identifies pancreatic ascites, and low
ascites glucose concentrations suggest malignant disease or tuberculosis.
•
Cytological
examination may reveal malignant cells (one-third of cirrhotic patients
with a bloody tap have a hepatoma).
•
.
•
Polymorphonuclear leucocyte counts above
•
250 ×
106/l strongly suggest infection (spontaneous bacterial peritonitis.
•
Laparoscopy
•
can be
valuable in
•
detecting peritoneal
•
disease.
•
Ultrasonography
•
is the
best means of confirming ascites, particularly in the obese and those with
small volumes of fluid. Paracentesis (if necessary under ultrasonic guidance)
can also be used to confirm the presence of ascites but is most useful for
obtaining ascitic fluid for analysis .
Management
Successful treatment of ascites relieves discomfort but does not prolong
life, and if over-vigorous, can produce serious disorders of fluid and
electrolyte balance and precipitate hepatic encephalopathy .
1-
Rest in bed
This improves renal blood flow and
lead to diuresis
2- Sodium and
water restriction
Restriction of dietary sodium intake is essential to achieving negative
sodium balance in patients with ascites. Restriction to 100 mmol/day ('no added
salt diet') may be adequate, but restriction to 40 mmol/day (which requires
close dietetic supervision) is necessary in more severe ascites.
Drugs containing relatively large amounts of
sodium and those promoting sodium retention, such as non-steroidal analgesic
agents, must be avoided .
Restriction of water intake to 0.5-1.0 litre/day is necessary only if
the plasma sodium falls below 125 mmol/l..
SOME DRUGS CONTAINING RELATIVELY LARGE
AMOUNTS OF SODIUM OR CAUSING SODIUM RETENTION
Avoid these medication
High sodium content
•
Antacids
•
Alginates
•
Antibiotics
•
Phenytoin
•
Sodium valproate
•
Effervescent preparations, e.g. aspirin,
calcium, paracetamol
Sodium retention
•
Carbenoxolone
•
Corticosteroids
•
Diazoxide
•
Metoclopramide
•
NSAIDs
•
Oestrogens
SOME ANTIBIOTICS WITH
A HIGH SODIUM CONTENT
A HIGH SODIUM CONTENT
Ampicillin
|
Amoxicillin
|
Cefotaxime
|
Benzylpenicillin
|
Cefradine
|
Cefoxitin
|
Cefuroxime
|
Ceftazidime
|
Flucloxacillin
|
Chloramphenicol
|
Ticarcillin
|
Piperacillin
|
3 - Diuretic drugs
The aim is to achieve wight loss 500 gm / d .
The aim is to achieve wight loss 500 gm / d .
If these is no peripheral oedema ,1000 gm / d
If
peripheral oedema is present .
•
Monotherapy :
Aldosterone antagonist ( spironolactone )
100 – 400 mg / d .
•
Combination theray :
Furosemide ( lasix ) + spironlactone
40 – 160 mg /d + 100 – 400 mg /d
Ratio 2 : 5
•
Patients who do not respond to doses of 400 mg
spironolactone and 160 mg furosemide are considered to have refractory or
diuretic-resistant ascites and should be treated by other therapeutic measures.
•
Refractory ascites
(
diuretic resistant ascites )
i-e Ascites not responding to salt. fluid
restriction and frusemide 160 mg + spironolactone 400 mg for at least 2 weeks .
•
Intractable ascites
( diuretic intractable ascites)
i.e Ascites can not be treated by duiretic
because of complications e.g encephalopathy
4 - Salt poor
albumin
I . V to increase plasma oncotic pressure
I . V to increase plasma oncotic pressure
•
-5- Therapeutic abdominal paracentesis
The first-line treatment of refractory ascites is large-volume paracentesis with intravenous albumin.
The first-line treatment of refractory ascites is large-volume paracentesis with intravenous albumin.
•
Paracentesis to dryness or the removal of 3-5 litres daily
is safe, provided the circulation is supported by giving intravenous colloid
such as human albumin (6-8 g per litre of ascites removed) or another plasma
expander.
•
Total paracentesis can therefore be used as an initial therapy or
when other treatments fail.
- Complications of paracentesis :
Hypovolemia - Encephalopathy
- Hepatorenal syndrome
- To avoid complications:
( selection criteria )
Tense ascites - Lower limb oedema
- Child grade B
- Prothrombin ≥ 40 %
- Serum bilirubin ≤ 10 mg / dl .
- Platelet ≥ 40.000 mm3 .
- S.creatinine ≤ 3 mg / dl .
- Urinary sodium ≥ 10 mmol / 24 hrs
.
If
ascites is resistant or refractory to the previous treatment, the following
causes must be considered and treated:
- Salt retention good regimen
- Marked hypoalbuminemia salt free albumin I.V
- Hyponatremia fluid restriction and stop
diuretic for few days then resume.
- T. B peritonitis
- Malignancy
- Decreased kidney function
- Weak diuretics
- Peritoneo-venous
(LeVeen) shunt
- The peritoneo-venous shunt is a long tube with a non-return valve running
subcutaneously from the peritoneum to the internal jugular vein in the
neck, which allows ascitic fluid to pass directly into the systemic
circulation.
- It is effective in ascites resistant to conventional treatment but complications,
including infection, superior vena caval thrombosis, pulmonary oedema,
bleeding from oesophageal varices and disseminated intravascular
coagulopathy, limit its use and insertion of these stents is now rare.
Ultra
filtration & reinfusion
Mechanism of Action :
Mechanism of Action :
•
Passage of
ascitic fhuid out side the body through a machine that can extract the excem
water and reintroduce the concentrated fluid through I.V set .
•
Side
effects :
-Peritonitis
- Volume
overload
Transjugular intrahepatic portosystemic stent shunt (TIPSS)
Transjugular intrahepatic portosystemic stent shunt (TIPSS)
( TIPSS )
TIPSS can relieve resistant ascites but does not prolong life. It can be
used where liver function is reasonable or in patients awaiting liver
transplantation, but should not be used in the terminally ill.
•
Prognosis Ascites is a serious development in
cirrhosis, as only 10-20% of patients survive 5 years from its appearance. The
outlook is not universally poor, however, and is best in those with
well-maintained liver function and where the response to therapy is good. The
prognosis is also better when a treatable cause for the underlying cirrhosis is
present or when a precipitating cause for ascites,
such as excess salt intake, is found.
Complications
•
Ascites may be complicated by renal failure and
also by infections which are spontaneous or, more commonly, precipitated by
invasive investigations or treatment, such as upper gastrointestinal endoscopy
and injection sclerotherapy.
•
Spontaneous Bacterial peritonitis
It is a precipitating factor of hepatic encephalopathy
It is a precipitating factor of hepatic encephalopathy
•
Consider it if a patient with liver cirrhosis
and ascites deteriorate progressively without obvious precipitating cause .
•
The organism gain acceSS to the peritoneum by
hematogenous spread.
C P :
- Fever , abdominal pain , rebound tenderness
- Marked
deterioration in patient with l¢ , ascites .
- It
may be silent .
Investigation :
Ascetic fluid ≥ 250 PNL / m3
Culture
E . Coli klebsiella
Treatment :
Third generation cephalosporin 4 gm / d .
No comments:
Post a Comment